Rick E Winningham
2006 - Innoviva
In 2006, Rick E Winningham earned a total compensation of $2.3M as Chief Executive Officer at Innoviva.
Compensation breakdown
| Non-Equity Incentive Plan | $332,395 |
|---|---|
| Option Awards | $1,269,852 |
| Salary | $716,223 |
| Total | $2,318,470 |
Winningham received $1.3M in option awards, accounting for 55% of the total pay in 2006.
Winningham also received $332.4K in non-equity incentive plan and $716.2K in salary.
Rankings
In 2006, Rick E Winningham's compensation ranked 1,485th out of 7,022 executives tracked by ExecPay. In other words, Winningham earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,485 out of 7,022 | 79th |
Division Manufacturing | 461 out of 2,413 | 81st |
Major group Chemicals And Allied Products | 84 out of 673 | 88th |
Industry group Drugs | 46 out of 518 | 91st |
Industry Pharmaceutical Preparations | 38 out of 355 | 89th |
Source: SEC filing on March 9, 2009.
Winningham's colleagues
We found two more compensation records of executives who worked with Rick E Winningham at Innoviva in 2006.
News
Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
April 5, 2024
Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
March 22, 2021
Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
March 24, 2020
Theravance Biopharma Former Senior Vice President, Corporate Development and Strategy Shehnaaz Suliman's 2018 pay falls 35% to $2.7M
March 20, 2019